|
|
| | 3,6,9,12,15-Pentaoxaheptadecan-1-ol, 17-[(tetrahydro-2H-pyran-2-yl)oxy]-, 1-methanesulfonate Basic information |
| Product Name: | 3,6,9,12,15-Pentaoxaheptadecan-1-ol, 17-[(tetrahydro-2H-pyran-2-yl)oxy]-, 1-methanesulfonate | | Synonyms: | 3,6,9,12,15-Pentaoxaheptadecan-1-ol, 17-[(tetrahydro-2H-pyran-2-yl)oxy]-, 1-methanesulfonate | | CAS: | 42607-89-6 | | MF: | C18H36O10S | | MW: | 444.54 | | EINECS: | | | Product Categories: | | | Mol File: | 42607-89-6.mol | ![3,6,9,12,15-Pentaoxaheptadecan-1-ol, 17-[(tetrahydro-2H-pyran-2-yl)oxy]-, 1-methanesulfonate Structure](CAS/20210305/GIF/42607-89-6.gif) |
| | 3,6,9,12,15-Pentaoxaheptadecan-1-ol, 17-[(tetrahydro-2H-pyran-2-yl)oxy]-, 1-methanesulfonate Chemical Properties |
| Boiling point | 557.4±50.0 °C(Predicted) | | density | 1.18±0.1 g/cm3(Predicted) |
| | 3,6,9,12,15-Pentaoxaheptadecan-1-ol, 17-[(tetrahydro-2H-pyran-2-yl)oxy]-, 1-methanesulfonate Usage And Synthesis |
| Uses | Ms-PEG6-THP is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. | | IC 50 | PEGs | | References | [1] An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562 DOI:10.1016/j.ebiom.2018.09.005 |
| | 3,6,9,12,15-Pentaoxaheptadecan-1-ol, 17-[(tetrahydro-2H-pyran-2-yl)oxy]-, 1-methanesulfonate Preparation Products And Raw materials |
|